Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

13.78
Delayed Data
As of Sep 22
 +0.29 / +2.15%
Today’s Change
8.67
Today|||52-Week Range
14.55
+28.79%
Year-to-Date

Today’s Trading

Previous close13.49
Today’s open13.47
Day’s range13.45 - 13.81
Volume344,483
Average volume (3 months)888,901
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+121.89%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio16.8
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.75+2.06%
EBSEmergent BioSolution...+0.67+1.78%
MYOKMyoKardia Inc-2.05-4.34%
LXRXLexicon Pharmaceutic...-0.42-3.28%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.32
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts